• The Lancet Diabetes & Endocrinology in conversation with

  • By: The Lancet Group
  • Podcast
The Lancet Diabetes & Endocrinology in conversation with By cover art

The Lancet Diabetes & Endocrinology in conversation with

By: The Lancet Group
Listen for free

  • Summary

  • Editors at The Lancet Diabetes & Endocrinology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

    A monthly audio companion to the journal, this podcast covers a broad range of topics, from thyroid cancer to childhood obesity, the mechanisms of ageing to erectile dysfunction, and more.
    © 2024 The Lancet Group
    Show more Show less
Episodes
  • Márta Korbonits on mechanisms of ageing

    Márta Korbonits on mechanisms of ageing
    Feb 24 2023

    Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.

    Read the full article:
    Mechanisms of ageing: growth hormone, dietary restriction, and metformin

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
    13 mins
  • Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus

    Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus
    Sep 20 2022

    Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective.

    Read the full article:
    Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
    8 mins
  • Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

    Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
    Jul 19 2022

    Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

    Read the full article:
    Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
    10 mins
Physical Illness & Disease Hygiene & Healthy Living Biological Sciences
Show more Show less

What listeners say about The Lancet Diabetes & Endocrinology in conversation with

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available